SI-Bone's iFuse Torq TNT implant system was used in its first patient cases since earning the FDA's breakthrough device designation, according to an Oct. 10 news release.
The device earned FDA clearance and breakthrough designation earlier in 2024, and it features a pelvis-specific design to improve fixation and reduce the risk of screw backout. It is designed to address anatomic and biomechanical challenges of pelvic fractures, especially in patients with poor bone quality.
Edward Westrick, MD, of Pittsburgh-based Allegheny General Hospital; Reza Firoozabadi, MD, of Seattle-based Harborview Medical Center; J.D. Black, MD, of Richland, Wash.-based Kadlec Regional Medical Center, and Brian Cunningham, MD, of St. Louis Park, Minn.-based Methodist Hospital – HealthPartners were among the first surgeons to use the device.